Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2019.00843
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

Elevated Anthranilic Acid Plasma Concentrations in Type 1 but Not Type 2 Diabetes Mellitus

Integrative Molecular Medicine
2015English

Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2011English

Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women

PLoS ONE
Multidisciplinary
2010English

Vervet Monkeys Vaccinated With Killed Leishmania Major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected Against Challenge Infection

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2001English

Anatomic Brain Asymmetry in Vervet Monkeys

PLoS ONE
Multidisciplinary
2011English

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Plasma Apolipoprotein A5 and Triglycerides in Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients

Clinical Pharmacology and Therapeutics
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy